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Fatty acid degradation in most organisms occurs primarily via the β-oxidation cycle. In mammals, β-oxidation occurs in both mitochondria
and peroxisomes, whereas plants and most fungi harbor the β-oxidation cycle only in the peroxisomes. Although several of the enzymes
participating in this pathway in both organelles are similar, some distinct physiological roles have been uncovered. Recent advances in the
structural elucidation of numerous mammalian and yeast enzymes involved in β-oxidation have shed light on the basis of the substrate specificity
for several of them. Of particular interest is the structural organization and function of the type 1 and 2 multifunctional enzyme (MFE-1 and MFE-
2), two enzymes evolutionarily distant yet catalyzing the same overall enzymatic reactions but via opposite stereochemistry. New data on the
physiological roles of the various enzymes participating in β-oxidation have been gathered through the analysis of knockout mutants in plants,
yeast and animals, as well as by the use of polyhydroxyalkanoate synthesis from β-oxidation intermediates as a tool to study carbon flux through
the pathway. In plants, both forward and reverse genetics performed on the model plant Arabidopsis thaliana have revealed novel roles for β-
oxidation in the germination process that is independent of the generation of carbohydrates for growth, as well as in embryo and flower
development, and the generation of the phytohormone indole-3-acetic acid and the signal molecule jasmonic acid.
© 2006 Elsevier B.V. All rights reserved.Keywords: β-oxidation; Metabolic compartmentalization; Fatty acid; Peroxisome; Multifunctional enzyme; Intermediary metabolism1. Introduction
Living organisms are exposed to a large variety of fatty
acids and their derivatives that can arise from either exogenous
sources or endogenous synthesis. The fatty acids and their CoA
esters play multiple roles in cellular processes by serving as
components in cellular lipids, carbon storage as triacylglycerols
or polyhydroxyalkanoates (in certain bacteria), regulators of
enzymes and membrane channels, ligands for nuclear recep-
tors, precursor molecules for hormones, signaling molecules
including second messengers, and substrates for α-, β-, and ω-
oxidations. Quantitatively, the major degradative pathway for
fatty acid esters is β-oxidation, which in animal cells takes
place in both mitochondria and peroxisomes and thus is an
example of metabolic compartmentalization. All peroxisomes
appear to accommodate fatty acid β-oxidation which, in most⁎ Corresponding author. Fax: +385 8 553 1141.
E-mail address: kalervo.hiltunen@oulu.fi (J.K. Hiltunen).
0167-4889/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2006.08.034fungi as well as in plants, seems to be solely a peroxisomal
process.
Both mitochondrial and peroxisomal β-oxidation catalyze
the chain shortening of acyl-CoA esters between carbons 2
and 3, yielding as products chain-shortened acyl-CoA and
acetyl-CoA or propionyl-CoA, depending on substrates. In
both organelles, degradation of straight-chain saturated fatty
acids requires the participation of the four activities
comprising the core of the β-oxidation cycle, namely acyl-
CoA dehydrogenase in mitochondria or acyl-CoA oxidase in
peroxisomes, enoyl-CoA hydratase, 3-hydroxyacyl-CoA de-
hydrogenase, and 3-ketoacyl-CoA thiolase and the reactions
proceed via 2E-enoyl-CoA, a chiral 3-hydroxyacyl-CoA and
3-ketoacyl-CoA intermediates. In contrast, degradation of
fatty acids with double bonds typically require the participa-
tion of auxiliary enzymes, including Δ3,Δ2-enoyl-CoA
isomerase, Δ3,5,Δ2,4-dienoyl-CoA isomerase and 2,4-die-
noyl-CoA reductase [1,2]. In addition to straight-chain
saturated and unsaturated fatty acids, the substrates of
peroxisomal β-oxidation can be acyl moieties carrying
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steroid nucleus [3,4] as well as phenoxy, indole or
cyclopentanone groups [5]. The substrate multiplicity sets
requirements regarding the catalytic properties of the enzymes in
the pathway. To meet these requirements, the peroxisomal β-
oxidation pathway has adopted several strategies. These include
evolution of enzymes towards a wide range of substrate
specificities, evolution of β-oxidation enzymes as paralogues
showing specificities with respect to their substrates, as well as
recruiting and optimizing enzymes from non-homologous
sources allowing them to catalyze a parallel set of reactions
with different substrate specificities [2]. The adaptation has been
fine-tuned by the development of systems controlling expression
of genes encoding β-oxidation enzymes in response to exposure
of the organism to different lipids, hormonal status, environ-
mental stress or developmental stages.
A part of the activities operating in the β-oxidation pathway
are catalyzed by multifunctional enzymes (MFEs) that carry out
consecutive chemical modifications. At least in some cases, the
metabolites are predicted to shuttle from one active centre to the
next without being detached from the protein [6–9]. This
substrate channelling provides efficient processing of metabo-
lites and ensures that they undergo all modifications provided
by the specific MFE.
The flux through β-oxidation requires reoxidation of NADH
and transfer of metabolites across the peroxisome membrane.
The permeability properties of the peroxisomal membrane,
peroxisomal channels and transporters as well as peroxisomal
disorders are discussed in depth elsewhere in this issue.
Although these aspects are linked to the theme of this article,
we will focus on the physiological function, current progress in
structural enzymology and enzymes linking modified acyl-
CoAs to peroxisomal β-oxidation.
2. Contribution of peroxisomal β-oxidation to the
metabolism
Peroxisomal β-oxidation in fungi, such as Saccharomyces
cerevisiae, is primarily devoted to the degradation of (often
extracellular) fatty acids for the subsequent use of acetyl-CoA
as a carbon and energy source for growth, although β-oxidation
was also shown to be involved in the endogenous turnover of
intermediates leaking out of the fatty acid biosynthetic pathway
[10]. Although the role of β-oxidation as a principal provider of
carbon and energy is also true for plants and animals, β-
oxidation in these hosts also has other physiological roles.
Much of our understanding on the physiological roles of
mammalian peroxisomal β-oxidation is based on the in vitro
characterization of kinetic properties of peroxisomal enzymes,
the identification of inborn deficiencies in peroxisomal fatty
acid oxidation and analyses of metabolite profiles in affected
individuals as well as generation of genetically modified
organisms [11,12]. Patients with a defect in peroxisomal β-
oxidation show neurological symptoms which are present at
birth or develop during childhood, but occasionally the
symptoms develop only after adolescence. A hallmark of
peroxisomal β-oxidation in rodents, especially in liver tissue, isthe high inducibility of a particular set of enzymes of the
pathway, but not all, in a peroxisome proliferator receptor
(PPAR) α-dependent manner by feeding the animals with
peroxisome proliferators [13].
Long and medium chain-length unsaturated and saturated
fatty acids are well accepted as substrates by mitochondrial and
peroxisomal β-oxidations. There are, however, a set of fatty
acids and their derivatives which in mammals are practically β-
oxidized only by the peroxisomal pathway. These compounds
include long-chain dicarboxylic and very long-chain monocar-
boxylic fatty acids. Others are certain leukotriens and prosta-
glandins, carboxylic derivatives of some xenobiotics, isopren-
oid-derived fat soluble vitamins, and pristanic acid, a product of
theα-oxidation of phytanic acid. These various compounds with
long aliphatic carbon chain, which are often poorly soluble in
water, are transformed to more polar metabolites in peroxisomal
β-oxidation thus facilitating their elimination. Although the
mitochondria have the same enzyme machinery to metabolize
all the double bonds of polyunsaturated fatty acids, experi-
ments with isolated organelles have demonstrated that contrary
to mitochondrial β-oxidation, polyunsaturated fatty acids are
well oxidized in peroxisomes and slowly oxidized in
mitochondria [14]. Some of these acids can even inhibit
the fatty acid β-oxidation in mitochondria [15]. Low levels
of 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid [22:6(n-3)]
are found in tissues of Zellweger patients and mice with
deficient peroxisomes. These findings were originally taken as a
suggestion for the existence of a (peroxisomal) Δ4-desaturase.
However, this desaturase has not been found in mammals,
and according to the current view 22:6(n-3) can be generated
via a retroconversion pathway that includes chain-shortening
of 24:6(n-3) by one cycle through peroxisomal β-oxidation
[4,16]. The contribution of mammalian peroxisomal β-oxida-
tion in the generation of C24-bile acids from C27-hydroxyster-
oids derivatives of cholesterol is reviewed elsewhere in this
issue.
Our understanding of the physiological role of β-oxidation
in plants has been expanded considerably in the last few years.
The identification of mutants, through forward and reverse
genetics, in several β-oxidation enzymes has confirmed the
expected role of these enzymes in the degradation of reserve
lipids present in seeds of plants such as Arabidopsis thaliana
(see next subheadings for references and further details).
However, these same mutants have also revealed novel roles
for β-oxidation, including a requirement for the emergence of
the radicle from the seed coat, embryo and flower development,
production of jasmonic acid involved in wounding response and
the phytohormone indole-3-acetic acid.
Beyond its role in the breakdown of storage lipids, β-
oxidation in plants has been shown to be active in a variety of
tissues, including the developing seed of A. thaliana that
rapidly synthesizes fatty acids and triacylglycerides [17]. The
turnover of fatty acids via β-oxidation is particularly enhanced
in plants synthesizing unusual fatty acids, such as capric acid,
vernolic acid and ricinoleic acid, and underlies endogenous
mechanisms involved in recycling and keeping such unusual
fatty acids out of membrane lipids [18,19].
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In the peroxisomal β-oxidation cycle, the first reaction is
catalyzed by an acyl-CoA oxidase (ACOX) which is regarded
to be the main enzymatic step controlling the flux through the
pathway. All the known peroxisomal ACOX enzymes are
dimeric FAD-containing proteins which belong to the same
superfamily as tetrameric mitochondrial acyl-CoA dehydro-
genases. The typical feature of the superfamily is the central
β-strand domain followed by an α-helical domain to which
FAD is bound [20]. The electrons fromFAD inACOXenzymes
are transferred directly to oxygen to generate H2O2 whereas the
mitochondrial acyl-CoA dehydrogenases pass electrons to the
respiratory chain via electron transferring flavoprotein.
The substrate diversity accepted in the peroxisomal β-
oxidation pathway is exemplified by the existence of three acyl-
CoA oxidase genes in mammals. The rodent ACOX1
(palmitoyl-CoA oxidase) is inducible in livers by peroxisome
proliferators and catalyzes the oxidation of long and medium
straight chain substrates but shows very low activities towards
short chain substrates [21]. This kinetic property of mammalian
ACOX1 agrees well with the data obtained by many
laboratories with isolated peroxisomal enzymes in vitro, namely
the β-oxidation of straight chain fatty acids in mammalian
peroxisomes does not proceed to completion. This notion is
supported further by the presence of carnitine octanoyl
transferase in peroxisomes [22,23] providing a carnitine
dependent mechanism for export of medium chain fatty acid
generated in mammalian peroxisomes. Disruption of Acox1 in
mice results in infertility, retarded postnatal growth and liver
abnormalities [24]. The other two oxidases in rat liver are
named pristanoyl-CoA oxidase (ACOX2) and cholestanoyl-
CoA oxidase (ACOX3), based on their substrate specificities. In
humans, di- and trihydroxycholestanoyl-CoAs are oxidized by
the same oxidase that oxidizes the other branched-chain acyl-
CoA esters. Humans also have a third acyl-CoA oxidase gene
that is a homolog of the rat ACOX3, but this gene appears to be
non-functional [25].
S. cerevisiae has only one peroxisomal acyl-CoA oxidase,
Pox1p/Fox1p, and therefore pox1Δ mutant cells are unable to
grow on oleic acid as the only carbon source. The complete β-
oxidation of oleic acid suggests that the active site of Pox1p/
Fox1p has acquired a broad ligand binding property concerning
the chain length of the acyl group in substrates. Unlike S.
cerevisiae, many other yeasts like Candida tropicalis or Yar-
rowia lipolytica have several acyl-CoA oxidases with different
chain length specificities [26].
Although acyl-CoA oxidases have been identified and
cloned from a few plant species, the best description has been
obtained from A. thaliana. The genome of A. thaliana contains
6 genes showing high homology to the mammalian acyl-CoA
oxidases, of which only 4 have been characterized biochemi-
cally. ACX1 is a medium- to long-chain acyl-CoA oxidase with
a substrate optimum of C14:0, ACX2 has optimum activity with
long-chain saturated and unsaturated acyl-CoAs (C14:0 to
C20:0), ACX3 exhibits medium-chain substrate specificity
(C8:0–C14:0) and ACX4 exhibits short-chain substrate spec-ificity (C4:0–C8:0) [27–30]. The presence of a short-chain
acyl-CoA oxidase enables to complete k-oxidation of fatty acids
in plant peroxisomes, similar to fungal peroxisomes. Interest-
ingly, phylogenetic analysis showed that ACX4 clusters with
mitochondrial acyl-CoA dehydrogenase rather than acyl-CoA
oxidase, suggesting that it arose from an acyl-CoA dehydroge-
nase that acquired a peroxisomal targeting sequence during
evolution [27]. The X-ray structure of ACX1 revealed that the
enzyme is a dimer and that it has a fold resembling that of
mammalian acyl-CoA oxidase [31].
Lipid degradation during germination and subsequent post-
germinative growth was found to be unaffected in an A.
thaliana acx1 knockout mutant and only slightly delayed in an
acx2 mutant, indicating the partially redundant nature of these
enzymes [32]. However, the double mutant acx1/acx2 was
found to be unable to catabolize storage lipids and accumulated
long-chain acyl-CoAs, in line with an early block of the β-
oxidation cycle. Post-germinative seedling growth and estab-
lishment of photosynthetic competency were severely compro-
mised in the double mutant, but were normal if sucrose was
provided to the media, indicating that the effect of the blockage
of the β-oxidation on post-germinative growth was mainly
related to the provision of carbon and energy for growth.
Interestingly, it was also found that the double mutant had a
significant decrease in germination frequency that could not be
alleviated by addition of exogenous sucrose, demonstrating a
role for β-oxidation in germination that goes beyond the simple
provision of carbon and energy [32].
While no phenotypes have been observed throughout the life
cycle in the single mutants acx3 and acx4, despite the large
reduction in medium- and short chain acyl-CoA oxidase
activity, respectively, the double mutant acx3/acx4 aborted
during the first phase of embryo development, suggesting an
important role for the β-oxidation of short-chain acyl-CoA
esters in development [33].
Indole-3-butyric acid (IBA) is an endogenous plant hormone
of the auxin class that can be converted to indole-3-acetic acid
(IAA) via one round of β-oxidation. Several mutants shown to
be resistant to the effects of IBA on root growth were deficient
in enzymes of the β-oxidation cycle [34]. Similarly, 2,4-
dichloro-phenoxy-butyric acid (2,4-DB) can be converted by β-
oxidation to 2,4-dichloro-phenoxy-acetic acid (2,4-D), which
has herbicide and auxin-like activity in plant cells, and plants
resistant to the action of 2,4-DB were blocked in various steps
of β-oxidation. The mutants acx1, acx3 and acx4 have
increased resistance to IBA, while only acx3 and acx4 were
more resistant to 2,4-DB [32,35]. Although the link between
resistance to IBA/2,4-DB action and the β-oxidation has been
shown repeatedly, the fact that mutants in acyl-CoA oxidases
having different chain-length specificities, such as acx1 and
acx4, show similar resistance to IBA suggests that the response
defects to IBA, and perhaps also to 2,4-DB, in these mutants
may be a more indirect block on peroxisomal metabolism than a
direct implication of acyl-CoA activity on these substrates [35].
Jasmonic acid (JA) is an important signalling molecule
involved in the response of plants to wounding and pathogen
attack. JA synthesis implicates the β-oxidation of the precursor
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(OPC:8). Of all four A. thaliana acx mutants tested, only acx1
showed a decrease in JA accumulation after wounding,
implicating more directly the action of ACX1 in synthesis of
JA [32,36]. Mutants in which the homologous tomato protein
LeAPX1A was deficient, also revealed lack of JA synthesis in
leaves, and recombinant LeAPX1A was shown to be active on
OPC:8 [37].
4. Multifunctional enzymes
Similarly to the mammalian inner membrane bound mito-
chondrial or bacterial cytoplasmic β-oxidations, the peroxisom-
al system includesMFEwhich catalyzes the second and the third
reactions of the pathway (Fig. 1A). The simultaneous existenceFig. 1. Structural information of eukaryotic peroxisomal multifunctional enzymes type
enoyl-CoAs (left) serve as substrates for the 2-enoyl-CoA hydratases producing 3-h
(right) by the 3-hydroxyacyl-CoA dehydrogenases. MFE-1 and MFE-2 perform op
specific for the S-stereoisomer and MFE-2 for the R-isomer. (B) Composition of MFE
in the middle with the N-terminus on the left and the C-terminus on the right. The up
and one 2-enoyl-CoA hydratase in a typical yeast (Candida tropicalis) MFE-2, while t
of each enzymatic domain followed by a domain homologous to sterol carrier protein
rectangles as ribbon drawings with one monomer per structure indicated. The struct
Composition of humanMFE-1 polypeptide from its functional domains with a combin
dehydrogenase in the middle and a domain ”X”with unknown function in the C-termi
a ribbon drawing below the polypeptide structure. The Protein Data Bank (www.r
structures used in the drawings are (from left to right and from up to down) 2et6, 1of MFE-1 (also known as L-bifunctional protein, LBP) and
MFE-2 (D-bifunctional protein, DBP) in mammalian peroxi-
somes catalyzing the same set of reactions via mirror image
stereochemistry is intriguing [38]. They enjoy a substantial
scientific interest because they are not sequence related, have
different evolutionary origins and thus are representatives of
functional convergence. Their enzymatic and functional prop-
erties are different, their interdomain organization shows unique
features as reflected by the substrate profiling and predicted
channeling between catalytic sites in different domains.
4.1. Peroxisomal multifunctional enzyme type 2 (MFE-2)
MFE-2 proteins from yeasts [39] and mammals [40] harbor
in each case three functional domains in one polypeptide1 (MFE-1) and type 2 (MFE-2). (A) Basic reactions catalyzed by the MFEs. 2E-
ydroxyacyl-CoAs (middle), which in turn are transformed to 3-ketoacyl-CoAs
posite stereochemistry with respect to the 3-hydroxy group with MFE-1 being
-2 polypeptides from their functional domains is shown as schematic rectangles
per rectangle indicates the presence of two 3-hydroxyacyl-CoA dehydrogenases
he lower rectangle shows the corresponding structure for humanMFE-2 with one
2. The corresponding domain crystal structures are shown above and below the
ures have been determined by producing the domains as separate proteins. (C)
ed 2-enoyl-CoA hydratase 1/isomerase in the N-terminus, a 3-hydroxyacyl-CoA
nus. The crystal structure of the dehydrogenase domain is known and is shown as
csb.org) accession codes for the atomic coordinates of the determined crystal
pn4, 1zbq, 1s9c, 1ikt and 1zcj, respectively.
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The function of MFE-2 is crucial not only for fatty acids
utilization via β-oxidation, but also for lipid metabolism in
general [11], as this enzyme contributes to the synthesis of
bile acids and docosahexaenoic acid [12,16]. Recently, a
genotype-phenotype correlation for D-bifunctional protein
deficiency was demonstrated by structural analysis of MFE-2
domain crystal structures in the light of mutational data from a
patient cohort [41]. MFE-2 protein in patients with milder
symptoms was found to contain point mutations in locations that
disturb the structural and functional architecture of the protein
less than such mutations that are known to cause total inactivity
of MFE-2, and thus severe disease symptoms.
The structure of the dehydrogenase domain of MFE-2 is
known from rat [42], human [43] and the yeast C. tropicalis
[44]. The overall structures are all identical with a notable 60-
residue C-terminal extension to the Rossmann-fold core not
found in other structurally related proteins. Differences in
structural details are seen corresponding to subtle functional
differences, mainly concerning substrate specificities. At the
tertiary/quaternary structural levels, an immediate observation
from the dimeric dehydrogenases in a dimeric MFE-2 protein is
that the C-terminal domain from one monomer folds on the top
of the substrate binding tunnel of the other monomer, and vice
versa. This way the monomers contribute to the active site
architectures of each other in a cooperative manner, strength-
ening also the monomer–monomer interactions. This structural
feature gains even more importance in the case of yeast
dehydrogenase dimers, where the two dehydrogenase units are
part of the same polypeptide chain due to a duplication (Fig.
1B). There the necessity for cooperation in substrate binding is
especially clearly demonstrated and correlated with the structure
[44,45], namely the dehydrogenase A cannot use short chain
fatty-acyl-CoAs as substrates, while the dehydrogenase B
accepts these more readily than the long chain ones.
The structures of the yeast C. tropicalis [46] and human [47]
hydratase 2 domains of MFE-2 were the first eukaryotic (R)-
specific hydratase structures determined (Fig. 1B). Comparison
with a bacterial (R)-hydratase [48] revealed the structural basis
for the adaptation of the eukaryotic enzyme to accept long chain
substrates: the absence of a long central α-helix from one of the
two “hot-dog” folds (the N-terminal one) leaves half of the
dimeric protein without enzymatic activity, but creates an extra
binding space for bulky substrates, contrary to the bacterial
enzyme that is half the size, it forms homodimers and binds a
short chain substrate with every such fold. Thus, the adaptation
of the eukaryotic protein for bulky substrates has happened in
the evolution with a cost of one active site per equal volume of
polypeptide chain.
A substantial controversy surrounds the sterol carrier protein
2-like domain of MFE-2. Various gene fission and fusion events
have resulted in MFE-2 proteins that either combine SCP-2
differently or have it as a separate protein: for example, C.
elegans MFE-2 combines it with the dehydrogenase domain
leaving the hydratase 2 a separate protein, while D. melanoga-
ster combines both enzymatic domains leaving SCP-2 aside
[49]. This domain is from the structural point of view nothingmuch but a hydrophobic binding pocket (Fig. 1B) capable of
binding even such clearly non-physiological molecules as
Triton X-100 [50] in addition to sterol and fatty acid/acyl-CoA-
type ligands relevant for β-oxidation [51]. The role of a domain
homologous to SCP-2 as part of MFE-2 is not known.
Despite the lack of structural data from full-length MFE-2
proteins, plausible models based on the domain crystal
structures have been presented [44,47]. These models are
consistent with the biochemical data, and include the idea that
the domain contacts in mammalian and fungal MFE-2s must be
different (due to the different array of functional units), and a
possibility for a selective substrate channeling mechanism in
yeast MFE-2.
Search of the A. thaliana genome for proteins showing
homology to the yeast and mammalian MFE-2 identified ECH2,
a protein of 34 kDa showing 40% and 34 amino acid % identity
to the human and fungal enoyl-CoA hydratase 2 domain of
MFE-2, respectively (S. Goepfert and Y. Poirier, unpublished).
The protein contains no domain homologous to the 3R-
hydroxyacyl-CoA dehydrogenase domain of yeast or mamma-
lian MFE-2. The protein is targeted to the peroxisomes in both
yeast and plants. Enzymatic assays confirmed that ECH2 is a
monofunctional enoyl-CoA hydratase-2 catalyzing the revers-
ible conversion of 2E-enoyl-CoA to 3R-hydroxyacyl-CoA (S.
Goepfert, K. Hiltunen and Y. Poirier, unpublished). ECH2 was
shown to participate in vivo in the metabolism of fatty acids
with a cis unsaturated bond on an even-numbered carbon by the
conversion of the intermediate 3R-hydroxyacyl-CoA, generated
via the hydration of 2Z-enoyl-CoA by the MFE-1, to the 2E-
enoyl-CoA for further degradation through the core β-oxidation
cycle.
4.2. Peroxisomal multifunctional enzyme type 1 (MFE-1)
Peroxisomal MFE-1 was first identified from rat [52,53]. It is
one of the most abundant proteins in rodent peroxisomes and
has been a target in a large number of studies. In spite of
25 years of efforts, its physiological function remained
concealed and just during last years some light has been shed
on its role in metabolism.
MFE-1 is a monomeric 79 kDa protein showing 2-enoyl-
CoA hydratase 1, 3S-hydroxyacyl-CoA dehydrogenase as well
as Δ3,Δ2-enoyl-CoA isomerase activities. Amino acid se-
quence comparisons with the monofunctional 2-enoyl-CoA
hydratase 1 (crotonase), Δ3,Δ2-enoyl-CoA isomerase and 3S-
hydroxyacyl-CoA dehydrogenase together with the studies
exploiting engineered MFE-1 variants [54] have located
hydratase 1/isomerase activities to the N-terminal and dehy-
drogenase to C-terminal halves, respectively (Fig. 1C). Thus its
homologues in mitochondria are the α-chain of the membrane-
associated trifunctional enzyme and in bacteria the α-chain of
the soluble α2β2 fatty acid β-oxidation complex (FOM). Based
on multiple sequence alignment and mutational analysis, the
MFE-1 can be divided into five distinct domains referred as to
A, B, C, D, and E. Domain A provides the core of the hydratase/
isomerase fold and it has a shared active site pocket for
hydration and isomerisation. The crystal structure revealed that
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of Pseudomonas fragi FOM (PtFOM) [9], located between its
hydratase and dehydrogenase part.
The recent 1.9 Å crystal structure of the dehydrogenase part
of the rat MFE-1 [55] revealed that the domain C is the
dinucleotide binding domain present in the short-chain acyl-
CoA dehydrogenase family (SCHAD). Domain D is similar to
the dimerization domain of SCHAD. Domain E is about 120
amino acid residues long, carries the type 1 peroxisomal
targeting signal (PTS1) SKL, and has low sequence similarity
with dimerization domain of SCHAD suggesting that it arose
via a partial gene duplication. In MFE-1 a local 2-fold axis,
corresponding to the SCHAD dimer 2-fold axis, relates domain
D to the domain E and therefore this domain E prevents the
MFE-1 monomer from dimerizing similarly to in the SCHAD
dimer.
Similarly to MFE-2, MFE-1 shows broad substrate specific-
ity. It accepts short and long chain enoyl-CoA esters, CoA esters
of hydroxylated C27 bile acid synthesis intermediates and
dicarboxylic acids. No patients with MFE-1 deficiency has been
described, and Mfe-1 null mice do not show appreciable
changes in lipid metabolism and they are symptomless [56]. The
inactivation of the Amacr gene, encoding α-methylacyl-CoA
racemase (Amacr) in mice will disrupt the generation of bile
acids via Amacr-MFE-2-dependent pathway. The observed
residual C24 bile acids, about 20% of that found in the wild type
mice, indicated the existence of a parallel pathway. The kinetic
properties of MFE-1 allows together with CYP3A11 and
CYP46A1 to make an Amacr-independent pathway for the
generation of C24 bile acids [57].
It has been demonstrated that the rat peroxisomal MFE-1 can
rescue the growth of a mfe-2 null mutant yeast strain on oleic
acid which results in the change of stereochemistry of the yeast
endogenous β-oxidation pathway [38]. However, in humans
this complementation can be at most partial, because patients
with a deficiency in MFE-2 fail to thrive. A new aspect on the
physiological role of MFE-1 was recently shown by the
demonstration that the primary function of MFE-1 may be
involvement in oxidation of dicarboxylic acids [58].
MFE activity has been studied in cucumber, where four
different isozymes were characterized [59,60]. The gene
encoding for the 76.5 kDa isozyme was cloned and the protein
was shown to contain, in addition to a 2E-enoyl-CoA hydratase
and a3S-hydroxyacyl-CoAdehydrogenase, aΔ3,Δ2-enoyl-CoA
isomerase and a 3R-hydroxyacyl-CoA epimerase activity [61].
The epimerization of 3R-hydroxyacyl-CoA was shown to be
mediated by an epimerase rather than the combined activity of a
R- and S-specific hydratase by the identification of anN-terminal
fragment lacking crotonase activity but retaining Δ3,Δ2-enoyl-
CoA isomerase and a 3R-hydroxyacyl-CoA epimerase activity
[61]. The A. thaliana genome contains only 2 genes, named
AIM1 and MFP2, which encode proteins having extensive
homology to the cucumber MFE-1. While AIM1 is mostly
expressed in siliques and flowers and shows little expression
during germination and early post-germinative growth, MFP2
shows significant induction during germination and is highly
expressed during early post-germinative growth [62,63]. Themutant aim1 showed normal germination, seedling establish-
ment and growth of the leaves and rosettes [63]. However, upon
transition to reproductive growth, the aim1 mutant showed
abnormal flower development resulting in severely reduced
fertility. The aim1 mutant also had increased resistance to the
herbicide 2,4-DB. In contrasts, the mutant mfp2 showed a
sucrose-dependent reduction in post-germinative seedling es-
tablishment that could be rescued by sucrose addition in the
media, but was not different fromwild type for 2,4-DB resistance
[64]. Themfp2 seedlings catabolized storage lipids more slowly,
accumulated long-chain acyl-CoAs and the peroxisomes were
increased in size. However, when photosynthesis was estab-
lished, the mfp2 plant grew like wild type and produced flowers
and seeds normally. Interestingly, the double mutant aim1/mfp2
aborted during early stages of embryo development, in a manner
similar to the double mutant acx3/acx4. Together, these results
demonstrate that the physiological role of AIM1 and MFP2 can
be quite distinct although some overlaps exist during embryo
development. It is unknown at this point how the lack of AMI1
leads to abnormal flower development or how the lack of both
AIM1 andMFP2 blocks embryo development. It is possible that
β-oxidation may either decrease the amount of a compound
inhibiting flower or embryo development or be involved in the
generation of a molecule required for progression through these
developmental stages.
5. 3-Ketoacyl-CoA thiolases
The last reaction of the β-oxidation cycle is the thiolytic
cleavage of 3-ketoacyl-CoA to acetyl-CoA and acyl-CoA
shortened by two carbon atoms. The only X-ray structure
available for peroxisomal β-oxidation thiolases is the yeast
peroxisomal thiolase, Pot1p/Fox3p. This enzyme is a dimeric
protein with a subunit size of 45 kDa, similar to the peroxisomal
thiolases in other species, whereas the mitochondrial thiolases
are tetrameric. The Pot1p/Fox3p subunit consists of three
domains: two core domains, which have similar folds and a loop
domain of about 120 residues. The core domain fold into a
mixed five-stranded β-sheet, which is covered on each side by
α-helices. The active site in yeast thiolase is surrounded by
residues from two core domains and residues from the loop
domain [65].
Rat peroxisomes have three thiolases. Thiolase A, which is
constitutively expressed is active with straight chain substrates
of varying acyl chain length. Thiolase B, which is inducible by
peroxisome proliferators, has very similar properties as thiolase
A with respect to the substrate acceptance profile. The third
peroxisomal thiolase is SCP-2/3-ketoacyl-CoA thiolase (SCPx),
which is a 58 kDa protein housing N-terminally the thiolase and
C-terminally the SCP-2 domain [66–69]. After the import into
peroxisomes, SCPx can be cleaved yielding 46 kDa thiolase and
13 kDa SCP-2 domains, respectively. SCP-2 can arise also
separately because it has its own promoter on the SCPx gene.
SCPx has very broad substrate specificity, including cleavage of
2-methyl branched as well as straight chain 3-ketoacyl-CoA
esters. Humans have two thiolases: one is the human equivalent
of the rat peroxisomal thiolase and the other one is the human
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metabolite profile analysis of knockout mice and a recently
described patient with SCPx deficiency [41] indicate that SCPx
participates in the thiolytic cleavage of 2-methyl branched
substrates leading to the degradation of pristanic acid and
synthesis of bile acids.
Genes encoding 3-ketoacyl-CoA thiolases have been cloned
from numerous plant species. The A. thaliana genome contains
3 genes encoding peroxisomal 3-ketoacyl-CoA thiolase, of
which only one, namely KAT2/PED1, has been characterized in
some detail [70]. KAT2 was shown to be the main 3-ketoacyl-
CoA thiolase active during seed germination. Similar to the
acx1/acx2 double mutant, the kat2 mutant was shown to have
a sucrose-independent reduction in seed germination, while the
strong delay in post-germinative seedling growth was found to
be rescued by external sucrose, thus again indicating a distinct
role for β-oxidation in germination and seedling growth
[32,70]. The ped-1 mutant was also more resistant to the action
of IBA and 2,4-DB, and showed a decrease in the synthesis of
jasmonic acid following wounding [34,36,70,71,72]. The
substrate specificity of KAT2, as well as of the two other A.
thaliana 3-ketothiolases KAT1 and KAT5, has not been studied.
However, the activity of KAT2 towards acetoacetyl-CoA, the
accumulation of long-chain acyl-CoAs in the kat2 mutant as
well as the implication of this protein in jasmonic acid synthesis
suggest that KAT2 may have activity towards a broad range of
substrates [36,70,72].
6. Auxiliary enzyme systems
The generation of chain-shortened products by peroxisomal
β-oxidation can proceed only in the presence of mechanisms
continuously removing them. According to the current view, the
products leave peroxisomes either after hydrolysis to free acids
by acyl-CoA thioesterases or transesterification (Fig. 2). The
classic β-oxidation pathway is able to complete the breakdown
of saturated fatty acids or those having trans double bonds at
even-numbered position as well as 2S-methyl-branched fatty
acids if a methyl-branched acyl-CoA oxidase is present.
However, concerning cis or trans double bonds at odd-
numbered positions, or cis double bonds at even-numbered
positions, the degradation can be completed by combining the
actions of k3,Δ2-enoyl-CoA isomerase, Δ3,5,Δ2,4-dienoyl-CoA
isomerase and 2,4-dienoyl-CoA reductase together with the
core enzymes of the β-oxidation pathway [1,73,74].
6.1. Thioesterases
Acyl-CoA thioesterases/hydrolases (ACOTs) are a group of
enzymes that catalyze the hydrolysis of acyl-CoAs to the free
fatty acid and CoA, providing the potential to regulate
intracellular levels of acyl-CoAs, free fatty acids and CoASH.
The ACOTS have at least 12 family members in mammals
(ACOT1-ACOT12), which are localized in almost all cellular
compartments such as endoplasmic reticulum, cytosol, mito-
chondria and peroxisomes [75]. Although the physiological
functions of these enzymes are not yet fully understood, recentcloning and more in-depth characterization of acyl-CoA
thioesterases has assisted in the discussion of functions for
specific enzymes such as in the regulation and termination of
fatty acid oxidation in mitochondria and peroxisomes. ACOT3
and ACOT5 have been characterized as peroxisomal acyl-CoA
thioesterases showing preference toward long-chain and
medium-chain acyl-CoAs, respectively [76]. ACOT8 shows a
broad substrate specificity hydrolyzing straight and methyl-
branched chain acyl-CoAs, dicarboxyl-CoAs as well as bile
acid-CoA esters. This activity raises a question whether newly
formed primary bile acids leave peroxisomes as free acids and
subsequently undergo reactivation and conjugation extraperox-
isomally. Recently it has been shown that ACOT4 is a
peroxisomal highly specific succinyl-CoA thioesterase, sug-
gesting that peroxisomal β-oxidation of dicarboxylic acids can
also lead, in addition to medium chain-length dicarboxylic
acids, to the formation of succinate [77].
S. cerevisiae contains a single peroxisomal acyl-CoA
thioesterase, named Pte1p [78], which corresponds to ACOT8
in mice. The purified enzyme was shown to accept a broad range
of substrates, ranging from acetyl-CoA to oleic acid and methyl-
branched fatty acids [79]. While one study showed that deletion
of the PTE1 gene leads to a small but significant decrease in the
ability of cells to grow on oleic acid as themain carbon source, no
obvious effects were observed in a separate study with a similar
mutant [78,80]. Recently, analysis of the carbon flux through the
β-oxidation cycle in vivo using the synthesis of peroxisomal
polyhydroxyalkanoate (PHA) from the polymerization of the
3R-hydroxyacyl-CoAs as a marker revealed that degradation of
short straight-chain (heptanoic acid) and branched-chain fatty
acids (8-methyl-nonanoic acid) was severely compromised in the
pte1Δ mutant [79]. The poor catabolism of 8-methyl-nonanoic
acid in pte1Δ cells had a negative effect on the degradation of
normally well-metabolized fatty acids, such as 10Z-heptadece-
noic acid, and reduced the ability of the cells to grow efficiently
in media containing such fatty acids. These experiments
provided direct evidence that the peroxisomal acyl-CoA
thioesterase can be a key enzyme required for normal carbon
flux through the coreβ-oxidation cycle, most likely by keeping a
proper balance between free and CoA-esterified fatty acids, and
maintaining an available pool of free CoA by preventing its
sequestration into poorly metabolizable CoA esters.
6.2. 2,4-Dienoyl-CoA reductase
2,4-Dienoyl-CoA reductase has been purified from several
sources including mammalian mitochondria and peroxisomes,
yeast peroxisomes and bacteria [1,81]. The characterized
reductases are NADPH-dependent enzymes, converting 2,4-
dienoyl-CoA into 3E-enoyl-CoA end-product and, with excep-
tions the bacterial enzyme, are members of the SDR super-
family. The bacterial reductase is a flavin-containing enzyme
that produces 2E-enoyl-CoA [82]. Clinical cases have been
published, which clearly demonstrates the importance of 2,4-
dienoyl-CoA reductase [83,84]. These patients show a decrease
in reductase activity, but it remains unclear which isoform is
defective. However, the ultimately fatal deficiency of one
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other isoenzymes and that each of the isoforms has a unique
metabolic role.
The yeast S. cerevisiae has only peroxisomal 2,4-dienoyl-
CoA reductase encoded by the SPS19 gene [85]. According to
the suggested mechanism, reducing equivalents required in this
NADPH-dependent reaction are transferred from the cytosol to
peroxisomes by the α-ketoglutarate/isocitrate shuttle involving
both cytosolic and peroxisomal NADP(H)-dependent isocitrate
dehydrogenase [86].The in vivo requirement of the 2,4-dienoyl-
CoA reductase for the degradation of fatty acids with a cis
double bond on an even carbon has been demonstrated by the
failure of the sps19Δ strain to grow on petroselenic acid as the
main carbon source or to synthesize PHA on 10Z-heptadece-
noic acid [85,87]. The sps19Δ mutant was shown to be
competent to degrade the fatty acid 9E,12E-octadecadienoic
acid when grown the cells on plates containing this fatty acid as
a single carbon and energy source, indicating that the 2E ,4E-
dienoyl-CoA intermediate is a suitable substrate for the MFE-2
and that the core β-oxidation is sufficient to degrade
unsaturated fatty acids with a trans double bond on an evenFig. 2. Peroxisomal β-oxidation of fatty acyl-CoA, contributions of auxiliary enzyme
generated for exit out of peroxisomes. (A) Methyl-branched fatty acids will be meta
CoAs that serve as substrates for peroxisomal oxidases. When either 2,4-dienoyl-C
(poly)unsaturated fatty enoyl-CoAs, they enter into pathways catalyzed by 2,4-dieno
CoA isomerase (4). In yeast, 2,5-dienoyl-CoAs can also be metabolized directly by th
on several acyl-CoAs and β-oxidation intermediates. (B) Dependent on species and o
by citrate synthase, condensed to glyoxylate to form malate by malate synthase, tra
acetate by acetyl-CoA thioesterase. The generated medium-chain fatty acyl group can
free acids by acyl-CoA thioesterase. Succinyl-CoA, arising as a product of degrad
thioesterase. The generated C24 bile acyl-CoA can leave peroxisomes after being h
exists also peroxisomal bile acid conjugating enzyme (BAAT) in addition to the cytop
acetic acid can presumably be converted into the corresponding free acids by an acycarbon [88]. However, analysis of the degradation of 10E-
heptadecenoic acid using the synthesis of PHA as a tool to
monitor β-oxidation revealed that in wild type cells, approx-
imately half of the 10E-heptadecenoic acid was degraded via a
pathway involving the 2,4-dienoyl-CoA reductase while the
other half was degraded in a reductase-independent manner via
the core β-oxidation [87]. Furthermore, while sps19 mutant
could degrade 10E-heptadecenoic acid, a significant reduction
in the overall carbon flux through β-oxidation was observed in
the sps19Δ mutant compared to wild type, revealing the
requirement of the 2,4-dienoyl-CoA reductase for optimal
degradation of such fatty acids.
A gene encoding a peroxisomal 2,4-dienoyl-CoA reductase
from A. thaliana has recently been identified and shown to
functionally complement the yeast sps19Δ (S. Goepfert and Y.
Poirier, unpublished).
6.3. Δ3,Δ2-Enoyl-CoA isomerases
The Δ3,Δ2-enoyl-CoA isomerases are enzymes participat-
ing in the β-oxidation of unsaturated fatty acids in bothsystems to this process and fates of acetyl-CoA and chain-shortened acyl-groups
bolized by peroxisomal á-oxidation and Amacr (1) to generate 2S-methylacyl-
oA, 2,5-dienoyl-CoA or 3-enoyl-CoA intermediates appear while β-oxidizing
yl-CoA reductase (2), Δ3,Δ2-enoyl-CoA isomerase (3), and Δ3,5, Δ2,4-dienoyl-
e MFE-2 of the core β-oxidation cycle. Acyl-CoA thioesterases are likely to act
rgans, the generated acetyl-CoA can be condensed to oxaloacetate to form citrate
nsferred to carnitine by carnitine acetyltransferase, or hydrolyzed to form free
be transferred to carnitine by the carnitine octanoyltransferase or hydrolyzed to
ation of dicarboxylic acids, can be converted to succinate by a succinyl-CoA
ydrolyzed to free acids by an acyl-CoA thioesterase. The data on whether there
lasmic activity are contradictory. The CoA esters of jasmonic acid and indole-3-
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can catalyze the isomerisation of the 3Z and the 3E substrate
molecules of various acyl chain lengths into 2E-enoyl-CoA.
Mammalian cells have three isomerases each of them being a
member of isomerase/hydratase 1 superfamily: monofunc-
tional mitochondrial and peroxisomal enzymes and an
isomerase as a part of peroxisomal MFE-1 sharing the same
catalytic site as hydratase 1 [7,91]. Mammalian peroxisomal
monofunctional isomerase (PECI) of human and mice has in
addition to the hydratase/isomerase-like sequence, an extra
domain about 80 amino acids in length at its N-terminus
showing sequence similarity to the acyl-CoA binding protein
(ACBP). ACBP is predicted to be involved in the intracellular
acyl-CoA transport [20].
Two isomerase structures have been solved so far: the yeast
peroxisomal enzyme, which is a hexamer, consisting of a dimer
of trimers [92,93] and human and rat mitochondrial enzyme,
which is a trimer [94,95]. The percentage sequence identity
between the yeast peroxisomal isomerase and the human
mitochondrial isomerases (13%) is very low. However, the CoA
moiety is always bound in the same way, such that the thioester
oxygen binds in a conserved oxyanion hole formed by two
peptide NH-groups.
The most extensive enzymological characterization has been
done by Zhang et al. [96] who have reported on the kinetic
constants of rat mitochondrial and peroxisomal isomerases. The
mammalian peroxisomal MFE-1 catalyzes, among the other
isomerase reactions, the conversion of 2E,5Z-dienoyl-CoA into
3E,5Z-dienoyl-CoA. The product is a substrate for dienoyl-CoA
isomerase and thus the participation in dienoyl-CoA isomerase-
dependent degradation of (poly)unsaturated fatty acids has been
proposed in vivo function of peroxisomal MFE-1 in mammals.
Noteworthy, when the rat MFE-1 was expressed heterologously
in ECI1-deleted yeast strain, the growth on oleic acid was
restored, demonstrating that Δ3,Δ2-enoyl-CoA isomerisation is
functional in vivo [97].
Three genes encoding monofunctional peroxisomal Δ3,Δ2-
enoyl-CoA isomerases have been identified in A. thaliana and
shown to complement the yeast eci1Δ mutant using the PHA
assay with cells grown on 10Z-heptadecenoic acid (S. Goepfert
and Y. Poirier, unpublished).
6.4. Δ3,5,Δ2,4-Dienoyl-CoA isomerase
It was originally shown by Tserng and coworkers [98] that
β-oxidation of unsaturated fatty acids with double bond at odd-
numbered positions can be metabolized via an NADPH-
dependent pathway in rat liver involving Δ3,5,Δ2,4-dienoyl-
CoA isomerase [99]. Mammals have apparently only one gene
encoding this protein which can be targeted by N- or C-terminal
signal sequences into either mitochondria or peroxisomes [100].
The enzyme belongs to the isomerase/hydratase superfamily and
its crystal structure has been solved at the 1.5 Å resolution [101].
The S. cerevisiae genome contains a single gene, Dci1,
encoding a peroxisomal Δ3,5,Δ2,4-dienoyl-CoA isomerase.
Dci1p was shown to have a weak intrinsic Δ3,Δ2-dienoyl-
CoA isomerase activity in addition to a Δ3,5,Δ2,4-dienoyl-CoAisomerase activity [102]. The in vivo contribution of the
Δ3,5,Δ2,4-dienoyl-CoA isomerase to the degradation of unsat-
urated fatty acids remains enigmatic, since dci1Δ strains appear
to utilize oleic acid as well as wild type [102]. Comparison of
PHA monomer composition produced in dci1Δ and wild type
cells grown in media containing 10Z,13Z, nonadecadienoic acid
revealed that only a minor fraction of fatty acids was degraded
via a pathway implicating theΔ3,5,Δ2,4-dienoyl-CoA isomerase
(H. Bogdawa and Y. Poirier, unpublished). Analysis of the
degradation of the conjugated linoleic acid isomers 10E,12Z-
octadecadienoic acid by the S. cerevisiae cells revealed the
requirement of the 2,4-dienoyl-CoA reductase and the Δ3,Δ2-
enoyl-CoA isomerase but not the Δ3,5,Δ2,4-dienoyl-CoA
isomerase [103]. Furthermore, studies using PHA to analyze
the degradation of 9Z,11E-octadecadienoic acid revealed that
efficient catabolism of such a conjugated fatty acid was largely
independent of the Δ3,5,Δ2,4-dienoyl-CoA isomerase but
instead relied on the presence of a Δ3,Δ2-enoyl-CoA isomerase
[104]. This study indicated that while the conversion of the
intermediate 3Z,5E-dienoyl-CoA to 2E,5E-dienoyl-CoA by the
Δ3,Δ2-enoyl-CoA isomerase may be less thermodynamically
favorable compared to its conversion to 2E,4E-dienoyl-CoA by
the Δ3,5,Δ2,4-dienoyl-CoA isomerase, the main flux in yeast
occurs through the former pathway [105,106].
A plant gene encoding a peroxisomal Δ3,5,Δ2,4-dienoyl-
CoA isomerase in A. thaliana has recently been described
[107]. The AtDCI1 protein exhibited approximately 38% and
18% amino acid identity to the mammalian and yeastΔ3,5,Δ2,4-
dienoyl-CoA isomerase, respectively. The plant protein was
shown to have Δ3,5,Δ2,4-dienoyl-CoA isomerase activity in
vitro and to be able to complement in vivo the yeast dci1Δ
mutant in a PHA assay using 10Z,13Z-nonadecadienoic acid.
6.5. α-Methylacyl-CoA racemase (Amacr)
The α-oxidation of β-methyl-branched fatty acyl-CoAs,
which takes place in peroxisomes yields both R- and S-isoforms
of α-methyl-branched fatty acids and furthermore, all bile acid
intermediates are in the R-configuration. However, the first
enzymes in the β-oxidation cycle are stereospecific for S-
isoforms of their substrates [108]. Therefore, R-isoforms have
to be converted to the S-orientation by Amacr, first described by
Schmitz and Conzelmann [109] before β-oxidation. The
substrate specificity of Amacr is rather broad. Generally
speaking enzymes are known to have high enantiomeric
specificity, and thus, Amacrs are an exception to this, as they
interconvert R and S forms of a chiral centre.
Recently, the crystal structure of Amacr homologue from
Mycobacterium tuberculosis, referred to as MCR, has been
determined at the 1.8Å resolution [110]. The structure of this
enzyme has confirmed that it belongs to the superfamily III CoA
transferases. MCR is a dimeric enzyme, where the two subunits
are tightly interlocked, because the C-terminal extension folds
back on the N-terminal domain, such as to generate a large hole
which is filled by protruding helices of the other subunit [110].
Mammals have one gene encoding an Amacr protein which
has both N-terminal mitochondrial and C-terminal peroxisomal
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peroxisomal locations of Amacr in mammals. Patients with
Amacr deficiency have been described [112]. Amacr has also
recently been identified as a tissue biomarker for prostate [113]
and colon cancer tissues [114].
An Amacr−/− mouse strain has been generated and
partially analyzed [57]. As the mouse strain is not able to
carry out Amacr-dependent chain shortening of the side
chain of cholesterol during bile acid synthesis, this knock-
out strain was assumed to represent “life without bile acids”.
The bile acid levels in the mouse strain were reduced to
about 20% of that in Amacr+/+, while the C27 precursors
reached a level ∼100 times higher than the controls. The
Amacr−/− mice were surprisingly symptomless clinically
when kept on standard laboratory diet. However, when the
diet of Amacr−/− mice was fortified with phytol, some
Amacr−/− mice died within 2 weeks. This proposed that the
key function of Amacr is the elimination and detoxification
of methyl-branched fatty acids. The remaining bile acids
demonstrate the metabolic redundancy in bile acid synthesis,
allowing essential lipid absorption.
7. Comments and future aspects
Our understanding of the β-oxidation cycle has increased
significantly in the last years, particularly through the use of
genetics and structural biology. However, there are still
numerous gaps that need to be filled in. Future research should
focus on getting a deeper understanding of the physiological
contribution of the various enzymes participating in β-
oxidation of fatty acids. For example, the physiological
contribution of the evolutionary conserved Δ3,5,Δ2,4-dienoyl-
CoA isomerase remains enigmatic in all organisms, even in the
relative simple model system of S. cerevisiae. Concerted
efforts on using several model systems to study the
physiological contribution of β-oxidation should be maintained
and expanded, as such contributions may be distinct between
organisms. Furthermore, heterologous expression of β-oxida-
tion enzymes in model systems, such as yeast, is a powerful
tool that can be used to uncover functions. Deciphering the
structure–function relationships of the β-oxidation enzymes is
also likely to make key contributions leading to our
understanding of their role in metabolism. MFEs are of special
interest in this context. In mammals, a better understanding of
the physiological function of β-oxidation and of the patho-
physiology associated with mutations in the relevant genes is
essential if the long-term goal of therapy is to be met. In plants,
it will be interesting to know how β-oxidation contributes to
seed germination as well as to the development of the embryo
and flower. Such research may lead to the identification of
novel signaling molecules that are generated or degraded via
the β-oxidation cycle.
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